Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Gastric Adenocarcinoma · Esophagus Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Clinique de l'Europe, Amiens, France

    Contact: Principal Investigator (Fayçal HOCINE, Dr)
  • Hopital Privé Arras Les Bonnettes, Arras, France

    Contact: Principal Investigator (Bruno HUGUENIN, Dr)
  • Institut Sainte Catherine, Avignon, France

    Contact: Principal Investigator (Clémence TOULLEC, Dr)
  • Centre Hospitalier de Beauvais, Beauvais, France

    Contact: Principal Investigator (Hanifa AMMARGUELLAT, Dr)
  • CHU Besançon - Hôpital Jean Minjoz, Besançon, France

    Contact: Principal Investigator (Christophe BORG, Pr)
  • CHU Morvan, Brest, France

    Contact: Principal Investigator (Pierre-Guillaume POUREAU, Dr)
  • Clinique Pasteur Lanroze, Brest, France

    Contact: Principal Investigator (Veronique JESTIN-LE TALLER, Dr)
  • CH Cholet, Cholet, France

    Contact: Principal Investigator (You Heng LAM, Dr)
  • Centre Jean Perrin, Clermont-Ferrand, France

    Contact: Principal Investigator (Hervé DEVAUD, Dr)
  • CHU d'Estaing, Clermont-Ferrand, France

    Contact: Principal Investigator (Marine JARY, Dr)
  • Institut Andrée Dutreix - Clinique de Flandre, Coudekerque-Branche, France

    Contact: Principal Investigator (Jean-Philippe WAGNER, Dr)
  • Centre Georges François Leclerc, Dijon, France

  • Hôpital Nord-Ouest Villefranche-sur-Saône, Gleizé, France

    Contact: Principal Investigator (Jonathan OLESINSKI, Dr)
  • Centre Léon Bérard, Lyon, France

    Contact: Principal Investigator (Clélia COUTZAC, Dr)
  • Hôpital Saint Joseph, Marseille, France

    Contact: Principal Investigator (Hervé PERRIER, Dr)
  • Institut Paoli Calmettes, Marseille, France

    Contact: Principal Investigator (Christelle DE LA FOUCHARDIERE, Dr)
  • Hôpital Nord Franche Comté, Montbéliard, France

    Contact: Principal Investigator (Christophe BORG, Pr)
  • Centre Antoine Lacassagne, Nice, France

    Contact: Principal Investigator (Ludovic EVESQUE, Dr)
  • Hôpital Saint Louis, Paris, France

    Contact: Principal Investigator (Thomas APARICIO, Pr)
  • Hopital Europeen Georges Pompidou, Paris, France

    Contact: Principal Investigator (Aziz ZAANAN, Pr)
  • GH Diaconesses - Crois St Simon, Paris, France

    Contact: Principal Investigator (Olivier DUBREUIL, Dr)
  • Institut Mutualiste Montsouris, Paris, France

    Contact: Principal Investigator (Emilie SOULARUE, Dr)
  • CHU de Poitiers, Poitiers, France

    Contact: Principal Investigator (David TOUGERON, Pr)
  • CHU - Hôpital Robert Debré, Reims, France

    Contact: Principal Investigator (Olivier BOUCHE, Pr)
  • Institut Jean Godinot, Reims, France

    Contact: Principal Investigator (Damien BOTSEN, Dr)
  • CHU Rouen - Charles Nicolle, Rouen, France

    Contact: Principal Investigator (Frédéric DI FIORE, Dr)
  • ICO - Site René Gauducheau, Saint-Herblain, France

    Contact: Principal Investigator (Judith RAIMBOURG, Dr)
  • Institut de cancérologie Strasbourg Europe, Strasbourg, France

    Contact: Principal Investigator (Meher BEN ABDELGHANI, Dr)
  • CHU Nancy - Hôpital Brabois, Vandœuvre-lès-Nancy, France

    Contact: Principal Investigator (Marie MULLER, Dr)
Study leads
  • Christelle DE LA FOUCHARDIERE

    Principal Investigator

    Institut Paoli-Calmettes